FDA.reportPublic FDA data

Femynor 28 Day Pack

RxCUI
1796922
RxNorm name
Femynor 28 Day Pack
Display name
Femynor 28 Day Pack
Full name
Femynor 28 Day Pack
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:59

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FemynorNORGESTIMATE AND ETHINYL ESTRADIOLAmneal Pharmaceuticals NY LLC59bce25b-ee2c-4f06-afff-e5141d0636022016-05-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1796922

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
59bce25b-ee2c-4f06-afff-e5141d063602{21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Femynor 28 Day] [BPCK] · Femynor 28 Day Pack [PSN] · Femynor 28 Day Pack [SY]39These highlights do not include all the information needed to use FEMYNOR safely and effectively. See full prescribing information for FEMYNOR. FEMYNOR™ (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 198920160530